Bristol, Amgen, Teva CEOs Among Execs to Testify at House Drug Pricing Hearings Next Week
09/30/2020
After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry’s largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings at the House Committee on Oversight and Reform, according to a FiercePharma report.
Current and former executives from Celgene, Bristol Myers Squibb, Teva, Amgen, Mallinckrodt and Novartis will testify next Wednesday and Thursday on pricing and competition in the drug industry. The committee has also said it’ll subpoena AbbVie about Imbruvica and Humira, two pricey megablockbusters protected by dozens of patents.